<- Go Home
Seer, Inc.
Seer, Inc., a life sciences company, engages in developing and commercializing products to decode the biology of the proteome. It develops Proteograph Product Suite, an integrated solution that includes proprietary engineered nanoparticles, consumables, automation instrumentation, and software to perform proteomic analysis to provide a solution that can be incorporated by nearly any lab for research use only. The company intends to sell its products for research use only, which cover academic institutions, life sciences, and research laboratories, as well as biopharmaceutical and biotechnology companies for non-diagnostic and non-clinical purposes. It operates in China, Australia, Eastern Europe, Israel, and Japan. The company was formerly known as Seer Biosciences, Inc. and changed its name to Seer, Inc. in July 2018. Seer, Inc. was incorporated in 2017 and is headquartered in Redwood City, California.
Market Cap
$136.2M
Volume
467.7K
Cash and Equivalents
$37.6M
EBITDA
-$92.7M
Tax Rate Collected
N/A
Tax Rate Ratio
N/A
Gross Profit
$7.0M
Profit Margin
48.13%
52 Week High
$2.63
52 Week Low
$1.53
Dividend
N/A
Price / Book Value
0.40
Price / Earnings
-1.78
Price / Tangible Book Value
0.40
Enterprise Value
-$84.9M
Enterprise Value / EBITDA
0.96
Operating Income
-$98.8M
Return on Equity
22.03%
Return on Assets
-14.92
Cash and Short Term Investments
$247.6M
Debt
$26.5M
Equity
$344.7M
Revenue
$14.6M
Unlevered FCF
-$31.9M
Sector
Life Sciences Tools and Services
Category
N/A
Hedge Funds that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Professional Funds that own this company (and many other perks).
Upgrade to Yellowbrick PremiumYellowbrick Portfolios that own this stock
PREMIUM
Upgrade to Yellowbrick Premium to unlock the Yellowbrick portfolios that own this company (and many other perks).
Upgrade to Yellowbrick Premium